Our validated technology platform can produce orally active polyclonal antibodies|Steven Lydeamore,Chief Executive Officer,Immuron Ltd 00:10:00

Share On Facebook Share On Twitter

Mr. Lydeamore has 30 years international pharmaceutical experience, working in Australia, Canada and USA. Mr. Lydeamore brings valuable international experience having spent eleven years working at Canadian global pharmaceutical company Apotex Inc., and four years for Mayne Pharma (USA) Limited. This includes valuable experience in mergers and acquisitions, finance, business development, sales and marketing, manufacturing, and research and development.

Recent Videos